Lu-Wen Wang
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Histone Deacetylase Inhibitors Research 7
- Epigenetics and DNA Methylation 4
- Genomics, phytochemicals, and oxidative stress 3
- RNA modifications and cancer 3
-
- Hepatitis B Virus Studies 3
- Co-authors
- Zuojiong Gong (34 shared papers)Fan Yang (11 shared papers)Fangzhou Jiao (11 shared papers)Haiyue Zhang (9 shared papers)Wenbin Zhang (8 shared papers)Yao Wang (10 shared papers)Xun Li (6 shared papers)Hong Zhang (2 shared papers)
In The Last Decade
Lu-Wen Wang
46 papers receiving 931 citations
Peers
Comparison fields: 5 of 101
- Hepatology 111
- Pharmacology 114
- Clinical Biochemistry 63
- Epidemiology 213
- Cancer Research 89
Countries citing papers authored by Lu-Wen Wang
This map shows the geographic impact of Lu-Wen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Wen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Wen Wang more than expected).
Fields of papers citing papers by Lu-Wen Wang
This network shows the impact of papers produced by Lu-Wen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Wen Wang. The network helps show where Lu-Wen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu-Wen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 89 | |
| 2 | 2019 | 81 | |
| 3 | 2018 | 59 | |
| 4 | 2014 | 45 | |
| 5 | 2010 | 39 | |
| 6 | 2017 | 38 | |
| 7 | 2020 | 37 | |
| 8 | 2020 | 35 | |
| 9 | 2013 | 35 | |
| 10 | 2013 | 28 | |
| 11 | 2018 | 28 | |
| 12 | 2012 | 27 | |
| 13 | High mobility group box-1 protein inhibits regulatory T cell immune activity in liver failure in patients with chronic hepatitis B. | 2010 | 27 |
| 14 | 2014 | 25 | |
| 15 | 2019 | 24 | |
| 16 | 2019 | 22 | |
| 17 | 2015 | 21 | |
| 18 | 2010 | 20 | |
| 19 | Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. | 2004 | 20 |
| 20 | 2023 | 18 |
About Lu-Wen Wang
Lu-Wen Wang is a scholar working on Molecular Biology, Epidemiology, Hepatology, Rheumatology and Oncology, having authored 53 papers that have together received 944 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Epigenetics and DNA Methylation (4 papers), Advanced Glycation End Products research (4 papers), Pelvic floor disorders treatments (4 papers), Hepatitis B Virus Studies (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Hepatology (111 citations), Pharmacology (114 citations), Clinical Biochemistry (63 citations), Epidemiology (213 citations) and Cancer Research (89 citations). Lu-Wen Wang has collaborated with scholars based in China, Germany and Taiwan. Frequent co-authors include Zuojiong Gong, Fan Yang, Fangzhou Jiao, Haiyue Zhang, Wenbin Zhang, Yao Wang, Xun Li, Hong Zhang, Likun Wang and Fan Yang. Their work appears in journals such as International Journal of Molecular Sciences, World Journal of Gastroenterology, Biomedicine & Pharmacotherapy, Life Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.